Verastem (VSTM) Cash from Financing Activities (2011 - 2026)

Verastem (VSTM) recorded quarterly Cash from Financing Activities of $28.7 million in Q1 2026, down 70.9% quarter-over-quarter from $98.6 million in Q4 2025, and down 57.45% on a YoY basis from $67.4 million in Q1 2025.

Verastem (VSTM) Cash from Financing Activities (2011 - 2026) Analysis & Trends

Verastem's Cash from Financing Activities history runs 16 years deep, the most recent figure standing at $28.7 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 57.45% year-over-year to $28.7 million; the TTM figure through Mar 2026 stood at $224.6 million (up 85.04% YoY), while the FY2025 annual figure was $263.3 million, up 380.64% from the prior year.
  • Cash from Financing Activities was $28.7 million for Q1 2026 at Verastem, down from $98.6 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $98.6 million in Q4 2025 to a low of -$891000.0 in Q3 2023.
  • Historically, Cash from Financing Activities has averaged $33.3 million across 5 years, with a median of $25.5 million in 2022.
  • The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities slumped 103.48% in 2023, then surged 19708.89% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $25.6 million in 2022, then plunged by 101.74% to -$446000.0 in 2023, then surged by 266.37% to $742000.0 in 2024, then soared by 13186.12% to $98.6 million in 2025, then slumped by 70.9% to $28.7 million in 2026.
  • The last three Cash from Financing Activities figures came in at $28.7 million (Q1 2026), $98.6 million (Q4 2025), and $17.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Verastem 407.42 Mn 225.74 Mn 15.90 Mn 28.69 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 28.69 Mn
Mar 31, 2026 28.69 Mn
Dec 31, 2025 98.58 Mn
Dec 31, 2025 98.58 Mn
Sep 30, 2025 17.88 Mn
Sep 30, 2025 17.88 Mn
Jun 30, 2025 79.42 Mn
Jun 30, 2025 79.42 Mn
Mar 31, 2025 67.43 Mn
Mar 31, 2025 67.43 Mn
Dec 31, 2024 742,000.00
Dec 31, 2024 742,000.00
Sep 30, 2024 53.60 Mn
Sep 30, 2024 53.60 Mn
Jun 30, 2024 -405,000.00
Jun 30, 2024 -405,000.00
Mar 31, 2024 846,000.00
Mar 31, 2024 846,000.00
Dec 31, 2023 -446,000.00
Dec 31, 2023 -446,000.00